MedTrace Logo

Efficacy of Microcurrent Therapy After Eccentric Exercise

NCT02322489 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-06-09

No results posted yet for this study

Summary

15 participants will be included in the present study. They will attend two groups of three sessions (i.e. sessions 1-2-3 and sessions 4-5-6) spaced by 3 months:

* session 1 and 4 (performed a few days before the experimental session): session for participants to get familiarized with the test battery.
* session 2 and 5: experimental session (the test battery followed by the provocative task, the test battery, the one-hour "treatment" and the test battery again).
* session 3 and 6 (performed 2 days later): the test battery.

The test battery included flexibility, functional, pressure pain threshold tests.

The provocative task was an isokinetic eccentric task for knee flexors and extensors.

The treatment was either a microcurrent therapy or a placebo microcurrent therapy.

Conditions

  • Delayed Onset Muscle Soreness

Interventions

DEVICE

Microcurrent Therapy

Several electrodes are placed over the muscles involved in the provocative task. The microcurrent therapy is then started and lasts for one hour.

DEVICE

Sham microcurrent therapy

Several electrodes are placed over the muscles involved in the provocative task. The microcurrent therapy is then started but lasts only for five seconds.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Christophe Demoulin, PhD · University of Liege

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322489 on ClinicalTrials.gov